Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 2.45% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | -6.12% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | -53.05% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 3.64% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | -6.08% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 78.37% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 49.22% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | -1.69% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | -16.05% |
| 10 | Insight Molecular Diagnostics | 172.60 Mn | 143.67 Mn | 15,000.00 | -30.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.18% |
| Dec 31, 2025 | -20.90% |
| Sep 30, 2025 | -138.02% |
| Jun 30, 2025 | -78.75% |
| Mar 31, 2025 | -103.33% |
| Dec 31, 2024 | 2.19% |
| Sep 30, 2024 | 21.56% |
| Jun 30, 2024 | 41.45% |
| Mar 31, 2024 | -58.53% |
| Dec 31, 2023 | -35.67% |
| Sep 30, 2023 | -232.86% |
| Jun 30, 2023 | -155.72% |
| Mar 31, 2023 | 29.85% |
| Dec 31, 2022 | 20.16% |
| Sep 30, 2022 | 71.65% |
| Jun 30, 2022 | 69.32% |
| Mar 31, 2022 | 81.90% |
| Dec 31, 2021 | -758.65% |
| Sep 30, 2021 | 58.42% |
| Jun 30, 2021 | 15.59% |